AzTrials
AzTrials

Tobacco Use DisorderNCT07198828

Mobile Health (mHealth) Application for Smoking Cessation Among Adolescents in Indonesia

A study testing mHealth Smoking Cessation Application in people with Tobacco Use Disorder and Smoking Cessation, run by Gadjah Mada University at 1 site in Indonesia.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This mixed-methods study develops and evaluates a mobile health (mHealth) application for smoking cessation among Indonesian adolescents aged 13-15 years. The study uses a sequential exploratory approach with three phases: (1) qualitative research to inform app design; (2) app development using Rapid Application… Read more about this study

Who is it for?
Ages 13 to 15 yearsHealthy volunteers can take part
What is being tested?
mHealth Smoking Cessation Application
Could I receive a placebo?
No, everyone receives an active treatment
How many people
110 participants
Where
1 siteIndonesia
Study dates
1 Mar 2026to 31 Aug 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 15 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Phase 1 (Qualitative Study):
  • Adolescent smokers aged 13-15 years
  • Smoking at least one cigarette or vaping once per week
  • Key informants: teachers, parents, peers, healthcare workers with relevant experience
  • Phase 3 (RCT):
  • Adolescents aged 13-15 years
Show all 11Show fewer
  • Smoking at least 1 cigarette in the past week
  • Own smartphone with internet access
  • Living in Padang City during study period
  • Willing to participate until study completion
  • Desire to quit smoking

Who cannot join

  • Phase 3 (RCT):
  • Currently using other smoking cessation apps or programs
  • Planning to change schools or relocate outside Padang during study period
  • Have severe psychiatric or medical conditions requiring intensive treatment
  • Unable to use smartphone applications due to literacy or technical limitations

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Indonesia1 site
  • Multiple junior high schools and community health centers

    Padang, West Sumatra

    Multiple junior high schools and community health centers, +6285272803477, radianilmaskal@mail.ugm.ac.id

Other trials in Indonesia

About this study

Official title: Development and Evaluation of a Mobile Health (mHealth) Application for Smoking Cessation Among Adolescents in Indonesia: A Mixed Methods Randomized Controlled Trial

This mixed-methods study develops and evaluates a mobile health (mHealth) application for smoking cessation among Indonesian adolescents aged 13-15 years. The study uses a sequential exploratory approach with three phases: (1) qualitative research to inform app design; (2) app development using Rapid Application Development (RAD) model; and (3) a single-blind, two-arm randomized controlled trial comparing the mHealth intervention to paper-based materials. The intervention is grounded in the Unified Theory of Acceptance and Use of Technology (UTAUT2) and Transtheoretical Model (TTM). Primary outcome is smoking abstinence at 1-, 3-, and 6-month follow-ups measured through self-report questionnaires.

Read the detailed description

Adolescent smoking is a growing public health concern worldwide, and it is particularly prevalent in low- and middle-income countries (LMICs) such as Indonesia. According to the World Health Organization (WHO), nearly 6.5% of adolescents aged 13-15 years globally use tobacco, with Southeast Asia, including Indonesia, contributing a significant proportion of this population. The prevalence of smoking among Indonesian adolescents has escalated over the past decade, with national surveys indicating a sharp increase from 7.2% in 2013 to 9.1% in 2018 and even higher figures reported by the 2019 Global Youth Tobacco Survey (GYTS) at 19.2%. Although more recent estimates suggest a slight reduction to 7.4% in 2023, smoking among adolescents remains a major public health challenge in Indonesia. Especially since Indonesia is the only country in Asia that has not ratified the WHO Framework Convention on Tobacco Control (FCTC).

This condition is especially concerning given the strong empirical evidence of the detrimental effects of smoking on individual health, societal well-being, and the environment. Adolescent smoking is associated with numerous long-term health risks, including respiratory diseases, cardiovascular problems, and an increased likelihood of continuing smoking into adulthood. Furthermore, smoking during adolescence has been linked to mental health issues such as depression, anxiety, and suicidal ideation. Moreover, tobacco-related mortality is alarmingly high, with over 8 million deaths annually worldwide due to active smoking and exposure to secondhand smoke. In Indonesia, tobacco-related diseases contribute significantly to mortality, with an estimated 225,700 deaths annually attributed to smoking. Despite various tobacco control measures implemented in Indonesia, such as raising taxes on tobacco products, free smoking cessation consultation services, and establishing smoke-free zones, smoking rates among adolescents have remained persistently high.

Technology-based interventions, particularly mobile health (mHealth) applications, have emerged as promising tools for promoting smoking cessation. The widespread use of smartphones among adolescents, with Indonesia being the fourth-largest smartphone market globally, presents a unique opportunity to leverage mHealth interventions to reduce smoking rates. However, the effectiveness of mHealth applications for smoking cessation has shown inconsistent results, particularly in LMICs where accessibility, engagement, and content relevance may differ from those in high-income countries.

Previous studies have demonstrated that while mHealth applications can help individuals quit smoking in the short term, their long-term effectiveness remains unclear, especially among adolescent populations. There is a growing body of literature highlighting the importance of tailoring interventions to the unique needs of adolescents, taking into account developmental stages, peer influence, and social media dynamics. However, there is a significant gap in the availability of mHealth applications designed specifically for adolescents in Indonesia, and the existing tools often fail to integrate critical elements such as behavioral change techniques, social support, and interactive features.

This study aims to address these gaps by developing an innovative mHealth intervention designed specifically for adolescent smokers in Indonesia. The intervention will be grounded in behavioral change theories such as the Unified Theory of Acceptance and Use of Technology (UTAUT2) and the Transtheoretical Model (TTM). UTAUT2 will ensure that the app is accepted, used, and engaging for adolescents, taking into account the influence of peers, ease of use, and intrinsic motivation factors. TTM will guide the app design by allowing it to adapt to the adolescent's specific stage in the smoking cessation process, providing tailored content and support. Together, these frameworks will make the mHealth app both effective, promoting long-term behavior change, relevant for adolescent smokers and better smoking cessation outcomes in Indonesia.

Being tested
mHealth Smoking Cessation Application, Paper-based Control Materials
Medical subject headings
Tobacco Use Disorder, Smoking Cessation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • mHealth Smoking Cessation ApplicationBehavioural

    Participants receive the mHealth smoking cessation application with:

    • Educational content about smoking risks and cessation benefits
    • Motivational messages and progress tracking
    • Social support features
    • Interactive elements and quizzes
    • Monthly monitoring and support
  • Paper-based Control MaterialsBehavioural

    Participants receive paper-based smoking cessation module containing equivalent content:

    • Motivational content and cessation benefits
    • Ex-smoker success stories
    • Trigger identification and coping strategies
    • Weekly quizzes with prizes (online access)
    • Monthly check-ins
Study groups in NCT07198828
Study groupRoleWhat they receive
mHealth Intervention GroupExperimentalParticipants receive the mHealth smoking cessation application with: * Educational content about smoking risks and cessation benefits * Motivational messages and progress tracking * Social support features * Interactive elements and quizzes * Monthly monitoring and support
Receives: Behavioral: mHealth Smoking Cessation Application
Control GroupActive comparatorParticipants receive paper-based smoking cessation module containing equivalent content: * Motivational content and cessation benefits * Ex-smoker success stories * Trigger identification and coping strategies * Weekly quizzes with prizes (online access) * Monthly check-ins
Receives: Behavioral: Paper-based Control Materials

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Self-reported smoking abstinence measured through questionnaire (Yes/No response where Yes = abstinent, No = not abstinent)

    Measured: 1, 3, and 6 months post-intervention

Secondary outcomes (6)
  1. Smoking cessation self-efficacy using SEQ-12 (12-item Smoking Self-Efficacy Questionnaire)

    Scale range: 12-60, where higher scores indicate greater self-efficacy for smoking cessation

    Measured: Baseline, 1, 2, 3, and 6 months

  2. Motivation assessed via Richmond Test

    Scale range: 0-10, where higher scores indicate greater motivation to quit smoking

    Measured: Baseline, 1, 2, 3, and 6 months

  3. Social support measured through Multidimensional Scale of Perceived Social Support (MSPSS)

    Scale range: 12-84, where higher scores indicate greater perceived social support

    Measured: Baseline, 1, 2, 3, and 6 months

  4. Dependence level using Fagerström Test for Nicotine Dependence (FTND)

    Scale range: 0-10, where higher scores indicate greater nicotine dependence

    Measured: Baseline, 1, 2, 3, and 6 months

  5. App usage engagement measured through usage logs

    Frequency and duration of app usage tracked through automated logging system. Measured as number of sessions per week and average session duration in minutes

    Measured: Baseline, 1, 2, 3, and 6 months

  6. mHealth app usability measured through mHealth Usability Questionnaire (MAUQ)

    mHealth Usability Questionnaire (MAUQ) scores. Scale range: 18-126, where higher scores indicate better perceived usability of the mobile health application

    Measured: Time Frame: 1, 2, 3, and 6 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 Sep 2025
  2. Study start1 Mar 2026 (estimated)
  3. Primary completion31 May 2026 (estimated)
  4. Study completion31 Aug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
110 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07198828
Sponsor's protocol ID
KE-FK-0864-EC-2025
Status last verified
Feb 2026
First submitted
16 Sep 2025
Last updated
4 Feb 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: All individual participant data that underlie the results reported in this article, after deidentification.

Publications

  • Ilmaskal R, Prabandari YS, Oktaria V. Development and evaluation of a mobile health (mHealth) application for smoking cessation among adolescents in Indonesia: a mixed methods randomised controlled trial study protocol. BMJ Open. 2026 Feb 24;16(2):e112178. doi: 10.1136/bmjopen-2025-112178.

    PubMed 41734925

Questions about this trial

What is this clinical trial studying?

A study testing mHealth Smoking Cessation Application in people with Tobacco Use Disorder and Smoking Cessation, run by Gadjah Mada University at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 11 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 4 Feb 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Radian Ilmaskal, MPH (+6285272803477, radianilmaskal@mail.ugm.ac.id), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Self-reported smoking abstinence measured through questionnaire (Yes/No response where Yes = abstinent, No = not abstinent) (time frame: 1, 3, and 6 months post-intervention). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07198828, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Feb 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in